ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Hodgkin Lymphoma Treatment Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-13P6307
Home | Market Reports | Health| Health Conditions| Cancer
Global Hodgkin Lymphoma Treatment Market Insights Forecast to 2028
BUY CHAPTERS

Global Hodgkin Lymphoma Treatment Market Research Report 2025

Code: QYRE-Auto-13P6307
Report
January 2025
Pages:82
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Cell Medica Limited
Cellular Biomedicine Group Inc
Constellation Pharmaceuticals, Inc.
Curis
Faron Pharmaceuticals Oy
Fate Therapeutics, Inc
Gamida Cell Ltd.
Gilead Sciences Inc
Incyte Corporation
Merck& Co. Inc
Mirati Therapeutics Inc
Molecular Templates Inc.
NantKwest Inc

Hodgkin Lymphoma Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Hodgkin Lymphoma Treatment Market

Hodgkin Lymphoma Treatment Market

The global market for Hodgkin Lymphoma Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Hodgkin Lymphoma Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hodgkin Lymphoma Treatment.
The Hodgkin Lymphoma Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hodgkin Lymphoma Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hodgkin Lymphoma Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Hodgkin Lymphoma Treatment Market Report

Report Metric Details
Report Name Hodgkin Lymphoma Treatment Market
CAGR 5%
Segment by Type
  • Alocrest
  • ANK Program
  • Azacitidine
  • BMS-986016
  • BPX-501
  • Others
Segment by Application
  • Hospital
  • Clinic
  • Research Center
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Cell Medica Limited, Cellular Biomedicine Group, Inc., Constellation Pharmaceuticals, Inc., Curis, Inc., Faron Pharmaceuticals Oy, Fate Therapeutics, Inc., Gamida Cell Ltd., Gilead Sciences, Inc., Incyte Corporation, Merck & Co., Inc., Mirati Therapeutics Inc., Molecular Templates Inc., NantKwest, Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Hodgkin Lymphoma Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Hodgkin Lymphoma Treatment Market report?

Ans: The main players in the Hodgkin Lymphoma Treatment Market are Cell Medica Limited, Cellular Biomedicine Group, Inc., Constellation Pharmaceuticals, Inc., Curis, Inc., Faron Pharmaceuticals Oy, Fate Therapeutics, Inc., Gamida Cell Ltd., Gilead Sciences, Inc., Incyte Corporation, Merck & Co., Inc., Mirati Therapeutics Inc., Molecular Templates Inc., NantKwest, Inc.

What are the Application segmentation covered in the Hodgkin Lymphoma Treatment Market report?

Ans: The Applications covered in the Hodgkin Lymphoma Treatment Market report are Hospital, Clinic, Research Center

What are the Type segmentation covered in the Hodgkin Lymphoma Treatment Market report?

Ans: The Types covered in the Hodgkin Lymphoma Treatment Market report are Alocrest, ANK Program, Azacitidine, BMS-986016, BPX-501, Others

Recommended Reports

Lymphoma & Leukemia

Cancer Drug Therapies

Cancer Treatment Devices

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hodgkin Lymphoma Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Alocrest
1.2.3 ANK Program
1.2.4 Azacitidine
1.2.5 BMS-986016
1.2.6 BPX-501
1.2.7 Others
1.3 Market by Application
1.3.1 Global Hodgkin Lymphoma Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Center
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hodgkin Lymphoma Treatment Market Perspective (2020-2031)
2.2 Global Hodgkin Lymphoma Treatment Growth Trends by Region
2.2.1 Global Hodgkin Lymphoma Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Hodgkin Lymphoma Treatment Historic Market Size by Region (2020-2025)
2.2.3 Hodgkin Lymphoma Treatment Forecasted Market Size by Region (2026-2031)
2.3 Hodgkin Lymphoma Treatment Market Dynamics
2.3.1 Hodgkin Lymphoma Treatment Industry Trends
2.3.2 Hodgkin Lymphoma Treatment Market Drivers
2.3.3 Hodgkin Lymphoma Treatment Market Challenges
2.3.4 Hodgkin Lymphoma Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hodgkin Lymphoma Treatment Players by Revenue
3.1.1 Global Top Hodgkin Lymphoma Treatment Players by Revenue (2020-2025)
3.1.2 Global Hodgkin Lymphoma Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Hodgkin Lymphoma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Hodgkin Lymphoma Treatment Revenue
3.4 Global Hodgkin Lymphoma Treatment Market Concentration Ratio
3.4.1 Global Hodgkin Lymphoma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hodgkin Lymphoma Treatment Revenue in 2024
3.5 Global Key Players of Hodgkin Lymphoma Treatment Head office and Area Served
3.6 Global Key Players of Hodgkin Lymphoma Treatment, Product and Application
3.7 Global Key Players of Hodgkin Lymphoma Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Hodgkin Lymphoma Treatment Breakdown Data by Type
4.1 Global Hodgkin Lymphoma Treatment Historic Market Size by Type (2020-2025)
4.2 Global Hodgkin Lymphoma Treatment Forecasted Market Size by Type (2026-2031)
5 Hodgkin Lymphoma Treatment Breakdown Data by Application
5.1 Global Hodgkin Lymphoma Treatment Historic Market Size by Application (2020-2025)
5.2 Global Hodgkin Lymphoma Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Hodgkin Lymphoma Treatment Market Size (2020-2031)
6.2 North America Hodgkin Lymphoma Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Hodgkin Lymphoma Treatment Market Size by Country (2020-2025)
6.4 North America Hodgkin Lymphoma Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hodgkin Lymphoma Treatment Market Size (2020-2031)
7.2 Europe Hodgkin Lymphoma Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Hodgkin Lymphoma Treatment Market Size by Country (2020-2025)
7.4 Europe Hodgkin Lymphoma Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hodgkin Lymphoma Treatment Market Size (2020-2031)
8.2 Asia-Pacific Hodgkin Lymphoma Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Hodgkin Lymphoma Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Hodgkin Lymphoma Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hodgkin Lymphoma Treatment Market Size (2020-2031)
9.2 Latin America Hodgkin Lymphoma Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Hodgkin Lymphoma Treatment Market Size by Country (2020-2025)
9.4 Latin America Hodgkin Lymphoma Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hodgkin Lymphoma Treatment Market Size (2020-2031)
10.2 Middle East & Africa Hodgkin Lymphoma Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Hodgkin Lymphoma Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Hodgkin Lymphoma Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cell Medica Limited
11.1.1 Cell Medica Limited Company Details
11.1.2 Cell Medica Limited Business Overview
11.1.3 Cell Medica Limited Hodgkin Lymphoma Treatment Introduction
11.1.4 Cell Medica Limited Revenue in Hodgkin Lymphoma Treatment Business (2020-2025)
11.1.5 Cell Medica Limited Recent Development
11.2 Cellular Biomedicine Group, Inc.
11.2.1 Cellular Biomedicine Group, Inc. Company Details
11.2.2 Cellular Biomedicine Group, Inc. Business Overview
11.2.3 Cellular Biomedicine Group, Inc. Hodgkin Lymphoma Treatment Introduction
11.2.4 Cellular Biomedicine Group, Inc. Revenue in Hodgkin Lymphoma Treatment Business (2020-2025)
11.2.5 Cellular Biomedicine Group, Inc. Recent Development
11.3 Constellation Pharmaceuticals, Inc.
11.3.1 Constellation Pharmaceuticals, Inc. Company Details
11.3.2 Constellation Pharmaceuticals, Inc. Business Overview
11.3.3 Constellation Pharmaceuticals, Inc. Hodgkin Lymphoma Treatment Introduction
11.3.4 Constellation Pharmaceuticals, Inc. Revenue in Hodgkin Lymphoma Treatment Business (2020-2025)
11.3.5 Constellation Pharmaceuticals, Inc. Recent Development
11.4 Curis, Inc.
11.4.1 Curis, Inc. Company Details
11.4.2 Curis, Inc. Business Overview
11.4.3 Curis, Inc. Hodgkin Lymphoma Treatment Introduction
11.4.4 Curis, Inc. Revenue in Hodgkin Lymphoma Treatment Business (2020-2025)
11.4.5 Curis, Inc. Recent Development
11.5 Faron Pharmaceuticals Oy
11.5.1 Faron Pharmaceuticals Oy Company Details
11.5.2 Faron Pharmaceuticals Oy Business Overview
11.5.3 Faron Pharmaceuticals Oy Hodgkin Lymphoma Treatment Introduction
11.5.4 Faron Pharmaceuticals Oy Revenue in Hodgkin Lymphoma Treatment Business (2020-2025)
11.5.5 Faron Pharmaceuticals Oy Recent Development
11.6 Fate Therapeutics, Inc.
11.6.1 Fate Therapeutics, Inc. Company Details
11.6.2 Fate Therapeutics, Inc. Business Overview
11.6.3 Fate Therapeutics, Inc. Hodgkin Lymphoma Treatment Introduction
11.6.4 Fate Therapeutics, Inc. Revenue in Hodgkin Lymphoma Treatment Business (2020-2025)
11.6.5 Fate Therapeutics, Inc. Recent Development
11.7 Gamida Cell Ltd.
11.7.1 Gamida Cell Ltd. Company Details
11.7.2 Gamida Cell Ltd. Business Overview
11.7.3 Gamida Cell Ltd. Hodgkin Lymphoma Treatment Introduction
11.7.4 Gamida Cell Ltd. Revenue in Hodgkin Lymphoma Treatment Business (2020-2025)
11.7.5 Gamida Cell Ltd. Recent Development
11.8 Gilead Sciences, Inc.
11.8.1 Gilead Sciences, Inc. Company Details
11.8.2 Gilead Sciences, Inc. Business Overview
11.8.3 Gilead Sciences, Inc. Hodgkin Lymphoma Treatment Introduction
11.8.4 Gilead Sciences, Inc. Revenue in Hodgkin Lymphoma Treatment Business (2020-2025)
11.8.5 Gilead Sciences, Inc. Recent Development
11.9 Incyte Corporation
11.9.1 Incyte Corporation Company Details
11.9.2 Incyte Corporation Business Overview
11.9.3 Incyte Corporation Hodgkin Lymphoma Treatment Introduction
11.9.4 Incyte Corporation Revenue in Hodgkin Lymphoma Treatment Business (2020-2025)
11.9.5 Incyte Corporation Recent Development
11.10 Merck & Co., Inc.
11.10.1 Merck & Co., Inc. Company Details
11.10.2 Merck & Co., Inc. Business Overview
11.10.3 Merck & Co., Inc. Hodgkin Lymphoma Treatment Introduction
11.10.4 Merck & Co., Inc. Revenue in Hodgkin Lymphoma Treatment Business (2020-2025)
11.10.5 Merck & Co., Inc. Recent Development
11.11 Mirati Therapeutics Inc.
11.11.1 Mirati Therapeutics Inc. Company Details
11.11.2 Mirati Therapeutics Inc. Business Overview
11.11.3 Mirati Therapeutics Inc. Hodgkin Lymphoma Treatment Introduction
11.11.4 Mirati Therapeutics Inc. Revenue in Hodgkin Lymphoma Treatment Business (2020-2025)
11.11.5 Mirati Therapeutics Inc. Recent Development
11.12 Molecular Templates Inc.
11.12.1 Molecular Templates Inc. Company Details
11.12.2 Molecular Templates Inc. Business Overview
11.12.3 Molecular Templates Inc. Hodgkin Lymphoma Treatment Introduction
11.12.4 Molecular Templates Inc. Revenue in Hodgkin Lymphoma Treatment Business (2020-2025)
11.12.5 Molecular Templates Inc. Recent Development
11.13 NantKwest, Inc.
11.13.1 NantKwest, Inc. Company Details
11.13.2 NantKwest, Inc. Business Overview
11.13.3 NantKwest, Inc. Hodgkin Lymphoma Treatment Introduction
11.13.4 NantKwest, Inc. Revenue in Hodgkin Lymphoma Treatment Business (2020-2025)
11.13.5 NantKwest, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Cell Medica Limited
Cellular Biomedicine Group Inc
Constellation Pharmaceuticals, Inc.
Curis
Faron Pharmaceuticals Oy
Fate Therapeutics, Inc
Gamida Cell Ltd.
Gilead Sciences Inc
Incyte Corporation
Merck& Co. Inc
Mirati Therapeutics Inc
Molecular Templates Inc.
NantKwest Inc
List of Tables
 Table 1. Global Hodgkin Lymphoma Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Alocrest
 Table 3. Key Players of ANK Program
 Table 4. Key Players of Azacitidine
 Table 5. Key Players of BMS-986016
 Table 6. Key Players of BPX-501
 Table 7. Key Players of Others
 Table 8. Global Hodgkin Lymphoma Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Hodgkin Lymphoma Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 10. Global Hodgkin Lymphoma Treatment Market Size by Region (2020-2025) & (US$ Million)
 Table 11. Global Hodgkin Lymphoma Treatment Market Share by Region (2020-2025)
 Table 12. Global Hodgkin Lymphoma Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 13. Global Hodgkin Lymphoma Treatment Market Share by Region (2026-2031)
 Table 14. Hodgkin Lymphoma Treatment Market Trends
 Table 15. Hodgkin Lymphoma Treatment Market Drivers
 Table 16. Hodgkin Lymphoma Treatment Market Challenges
 Table 17. Hodgkin Lymphoma Treatment Market Restraints
 Table 18. Global Hodgkin Lymphoma Treatment Revenue by Players (2020-2025) & (US$ Million)
 Table 19. Global Hodgkin Lymphoma Treatment Market Share by Players (2020-2025)
 Table 20. Global Top Hodgkin Lymphoma Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hodgkin Lymphoma Treatment as of 2024)
 Table 21. Ranking of Global Top Hodgkin Lymphoma Treatment Companies by Revenue (US$ Million) in 2024
 Table 22. Global 5 Largest Players Market Share by Hodgkin Lymphoma Treatment Revenue (CR5 and HHI) & (2020-2025)
 Table 23. Global Key Players of Hodgkin Lymphoma Treatment, Headquarters and Area Served
 Table 24. Global Key Players of Hodgkin Lymphoma Treatment, Product and Application
 Table 25. Global Key Players of Hodgkin Lymphoma Treatment, Date of Enter into This Industry
 Table 26. Mergers & Acquisitions, Expansion Plans
 Table 27. Global Hodgkin Lymphoma Treatment Market Size by Type (2020-2025) & (US$ Million)
 Table 28. Global Hodgkin Lymphoma Treatment Revenue Market Share by Type (2020-2025)
 Table 29. Global Hodgkin Lymphoma Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 30. Global Hodgkin Lymphoma Treatment Revenue Market Share by Type (2026-2031)
 Table 31. Global Hodgkin Lymphoma Treatment Market Size by Application (2020-2025) & (US$ Million)
 Table 32. Global Hodgkin Lymphoma Treatment Revenue Market Share by Application (2020-2025)
 Table 33. Global Hodgkin Lymphoma Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 34. Global Hodgkin Lymphoma Treatment Revenue Market Share by Application (2026-2031)
 Table 35. North America Hodgkin Lymphoma Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. North America Hodgkin Lymphoma Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 37. North America Hodgkin Lymphoma Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Europe Hodgkin Lymphoma Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Europe Hodgkin Lymphoma Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 40. Europe Hodgkin Lymphoma Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 41. Asia-Pacific Hodgkin Lymphoma Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Asia-Pacific Hodgkin Lymphoma Treatment Market Size by Region (2020-2025) & (US$ Million)
 Table 43. Asia-Pacific Hodgkin Lymphoma Treatment Market Size by Region (2026-2031) & (US$ Million)
 Table 44. Latin America Hodgkin Lymphoma Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Latin America Hodgkin Lymphoma Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Latin America Hodgkin Lymphoma Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Middle East & Africa Hodgkin Lymphoma Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 48. Middle East & Africa Hodgkin Lymphoma Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 49. Middle East & Africa Hodgkin Lymphoma Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 50. Cell Medica Limited Company Details
 Table 51. Cell Medica Limited Business Overview
 Table 52. Cell Medica Limited Hodgkin Lymphoma Treatment Product
 Table 53. Cell Medica Limited Revenue in Hodgkin Lymphoma Treatment Business (2020-2025) & (US$ Million)
 Table 54. Cell Medica Limited Recent Development
 Table 55. Cellular Biomedicine Group, Inc. Company Details
 Table 56. Cellular Biomedicine Group, Inc. Business Overview
 Table 57. Cellular Biomedicine Group, Inc. Hodgkin Lymphoma Treatment Product
 Table 58. Cellular Biomedicine Group, Inc. Revenue in Hodgkin Lymphoma Treatment Business (2020-2025) & (US$ Million)
 Table 59. Cellular Biomedicine Group, Inc. Recent Development
 Table 60. Constellation Pharmaceuticals, Inc. Company Details
 Table 61. Constellation Pharmaceuticals, Inc. Business Overview
 Table 62. Constellation Pharmaceuticals, Inc. Hodgkin Lymphoma Treatment Product
 Table 63. Constellation Pharmaceuticals, Inc. Revenue in Hodgkin Lymphoma Treatment Business (2020-2025) & (US$ Million)
 Table 64. Constellation Pharmaceuticals, Inc. Recent Development
 Table 65. Curis, Inc. Company Details
 Table 66. Curis, Inc. Business Overview
 Table 67. Curis, Inc. Hodgkin Lymphoma Treatment Product
 Table 68. Curis, Inc. Revenue in Hodgkin Lymphoma Treatment Business (2020-2025) & (US$ Million)
 Table 69. Curis, Inc. Recent Development
 Table 70. Faron Pharmaceuticals Oy Company Details
 Table 71. Faron Pharmaceuticals Oy Business Overview
 Table 72. Faron Pharmaceuticals Oy Hodgkin Lymphoma Treatment Product
 Table 73. Faron Pharmaceuticals Oy Revenue in Hodgkin Lymphoma Treatment Business (2020-2025) & (US$ Million)
 Table 74. Faron Pharmaceuticals Oy Recent Development
 Table 75. Fate Therapeutics, Inc. Company Details
 Table 76. Fate Therapeutics, Inc. Business Overview
 Table 77. Fate Therapeutics, Inc. Hodgkin Lymphoma Treatment Product
 Table 78. Fate Therapeutics, Inc. Revenue in Hodgkin Lymphoma Treatment Business (2020-2025) & (US$ Million)
 Table 79. Fate Therapeutics, Inc. Recent Development
 Table 80. Gamida Cell Ltd. Company Details
 Table 81. Gamida Cell Ltd. Business Overview
 Table 82. Gamida Cell Ltd. Hodgkin Lymphoma Treatment Product
 Table 83. Gamida Cell Ltd. Revenue in Hodgkin Lymphoma Treatment Business (2020-2025) & (US$ Million)
 Table 84. Gamida Cell Ltd. Recent Development
 Table 85. Gilead Sciences, Inc. Company Details
 Table 86. Gilead Sciences, Inc. Business Overview
 Table 87. Gilead Sciences, Inc. Hodgkin Lymphoma Treatment Product
 Table 88. Gilead Sciences, Inc. Revenue in Hodgkin Lymphoma Treatment Business (2020-2025) & (US$ Million)
 Table 89. Gilead Sciences, Inc. Recent Development
 Table 90. Incyte Corporation Company Details
 Table 91. Incyte Corporation Business Overview
 Table 92. Incyte Corporation Hodgkin Lymphoma Treatment Product
 Table 93. Incyte Corporation Revenue in Hodgkin Lymphoma Treatment Business (2020-2025) & (US$ Million)
 Table 94. Incyte Corporation Recent Development
 Table 95. Merck & Co., Inc. Company Details
 Table 96. Merck & Co., Inc. Business Overview
 Table 97. Merck & Co., Inc. Hodgkin Lymphoma Treatment Product
 Table 98. Merck & Co., Inc. Revenue in Hodgkin Lymphoma Treatment Business (2020-2025) & (US$ Million)
 Table 99. Merck & Co., Inc. Recent Development
 Table 100. Mirati Therapeutics Inc. Company Details
 Table 101. Mirati Therapeutics Inc. Business Overview
 Table 102. Mirati Therapeutics Inc. Hodgkin Lymphoma Treatment Product
 Table 103. Mirati Therapeutics Inc. Revenue in Hodgkin Lymphoma Treatment Business (2020-2025) & (US$ Million)
 Table 104. Mirati Therapeutics Inc. Recent Development
 Table 105. Molecular Templates Inc. Company Details
 Table 106. Molecular Templates Inc. Business Overview
 Table 107. Molecular Templates Inc. Hodgkin Lymphoma Treatment Product
 Table 108. Molecular Templates Inc. Revenue in Hodgkin Lymphoma Treatment Business (2020-2025) & (US$ Million)
 Table 109. Molecular Templates Inc. Recent Development
 Table 110. NantKwest, Inc. Company Details
 Table 111. NantKwest, Inc. Business Overview
 Table 112. NantKwest, Inc. Hodgkin Lymphoma Treatment Product
 Table 113. NantKwest, Inc. Revenue in Hodgkin Lymphoma Treatment Business (2020-2025) & (US$ Million)
 Table 114. NantKwest, Inc. Recent Development
 Table 115. Research Programs/Design for This Report
 Table 116. Key Data Information from Secondary Sources
 Table 117. Key Data Information from Primary Sources
 Table 118. Authors List of This Report


List of Figures
 Figure 1. Hodgkin Lymphoma Treatment Picture
 Figure 2. Global Hodgkin Lymphoma Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Hodgkin Lymphoma Treatment Market Share by Type: 2024 VS 2031
 Figure 4. Alocrest Features
 Figure 5. ANK Program Features
 Figure 6. Azacitidine Features
 Figure 7. BMS-986016 Features
 Figure 8. BPX-501 Features
 Figure 9. Others Features
 Figure 10. Global Hodgkin Lymphoma Treatment Market Size by Application (2020-2031) & (US$ Million)
 Figure 11. Global Hodgkin Lymphoma Treatment Market Share by Application: 2024 VS 2031
 Figure 12. Hospital Case Studies
 Figure 13. Clinic Case Studies
 Figure 14. Research Center Case Studies
 Figure 15. Hodgkin Lymphoma Treatment Report Years Considered
 Figure 16. Global Hodgkin Lymphoma Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 17. Global Hodgkin Lymphoma Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global Hodgkin Lymphoma Treatment Market Share by Region: 2024 VS 2031
 Figure 19. Global Hodgkin Lymphoma Treatment Market Share by Players in 2024
 Figure 20. Global Top Hodgkin Lymphoma Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hodgkin Lymphoma Treatment as of 2024)
 Figure 21. The Top 10 and 5 Players Market Share by Hodgkin Lymphoma Treatment Revenue in 2024
 Figure 22. North America Hodgkin Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. North America Hodgkin Lymphoma Treatment Market Share by Country (2020-2031)
 Figure 24. United States Hodgkin Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Canada Hodgkin Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Hodgkin Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe Hodgkin Lymphoma Treatment Market Share by Country (2020-2031)
 Figure 28. Germany Hodgkin Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. France Hodgkin Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. U.K. Hodgkin Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Italy Hodgkin Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Russia Hodgkin Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Nordic Countries Hodgkin Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Hodgkin Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Hodgkin Lymphoma Treatment Market Share by Region (2020-2031)
 Figure 36. China Hodgkin Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Japan Hodgkin Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. South Korea Hodgkin Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Hodgkin Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. India Hodgkin Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Australia Hodgkin Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Hodgkin Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America Hodgkin Lymphoma Treatment Market Share by Country (2020-2031)
 Figure 44. Mexico Hodgkin Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Brazil Hodgkin Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Hodgkin Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa Hodgkin Lymphoma Treatment Market Share by Country (2020-2031)
 Figure 48. Turkey Hodgkin Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Hodgkin Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. UAE Hodgkin Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Cell Medica Limited Revenue Growth Rate in Hodgkin Lymphoma Treatment Business (2020-2025)
 Figure 52. Cellular Biomedicine Group, Inc. Revenue Growth Rate in Hodgkin Lymphoma Treatment Business (2020-2025)
 Figure 53. Constellation Pharmaceuticals, Inc. Revenue Growth Rate in Hodgkin Lymphoma Treatment Business (2020-2025)
 Figure 54. Curis, Inc. Revenue Growth Rate in Hodgkin Lymphoma Treatment Business (2020-2025)
 Figure 55. Faron Pharmaceuticals Oy Revenue Growth Rate in Hodgkin Lymphoma Treatment Business (2020-2025)
 Figure 56. Fate Therapeutics, Inc. Revenue Growth Rate in Hodgkin Lymphoma Treatment Business (2020-2025)
 Figure 57. Gamida Cell Ltd. Revenue Growth Rate in Hodgkin Lymphoma Treatment Business (2020-2025)
 Figure 58. Gilead Sciences, Inc. Revenue Growth Rate in Hodgkin Lymphoma Treatment Business (2020-2025)
 Figure 59. Incyte Corporation Revenue Growth Rate in Hodgkin Lymphoma Treatment Business (2020-2025)
 Figure 60. Merck & Co., Inc. Revenue Growth Rate in Hodgkin Lymphoma Treatment Business (2020-2025)
 Figure 61. Mirati Therapeutics Inc. Revenue Growth Rate in Hodgkin Lymphoma Treatment Business (2020-2025)
 Figure 62. Molecular Templates Inc. Revenue Growth Rate in Hodgkin Lymphoma Treatment Business (2020-2025)
 Figure 63. NantKwest, Inc. Revenue Growth Rate in Hodgkin Lymphoma Treatment Business (2020-2025)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Lymphoma Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Lymphoma Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hematological Malignancy Treatment Market Research Report 2025
Non Hodgkin Lymphoma Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Diffuse Large B Cell Lymphoma Drug Market Research Report 2024
Hematological Malignancies Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Mantle Cell Lymphoma Treatment Market Research Report 2025
T Cell Lymphoma Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Indolent Lymphoma Treatment Market Research Report 2025
Hematological Malignancy Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hematological Malignancies Disease Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Intraocular Lymphoma Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global B Cell Chronic Lymphocytic Leukemia Treatment Market Research Report 2024
B Cell Non Hodgkin s Lymphoma NHL Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cutaneous Cell Lymphoma Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cutaneous B Cell Lymphoma Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Central Nervous System CNS Lymphoma Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Small Lymphocytic Lymphoma Therapy Market Research Report 2025
Global Hodgkin s Lymphoma Drugs Market Research Report 2024
Global Small Lymphocytic Lymphoma Drug Market Research Report 2025

RELATED REPORTS

Global Fixation Device for Radiotherapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4H16852
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Group A Streptococcus for Injection Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37K16619
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Boron Neutron Capture Therapy System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30U16301
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Radioactive Glass Microsphere Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-2G16953
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions